monobromobimane has been researched along with ethyl n-alpha-acetyl-tyrosinate in 1 studies
| Studies (monobromobimane) | Trials (monobromobimane) | Recent Studies (post-2010) (monobromobimane) | Studies (ethyl n-alpha-acetyl-tyrosinate) | Trials (ethyl n-alpha-acetyl-tyrosinate) | Recent Studies (post-2010) (ethyl n-alpha-acetyl-tyrosinate) |
|---|---|---|---|---|---|
| 199 | 1 | 42 | 48 | 0 | 1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hudig, D; Redelman, D | 1 |
1 other study(ies) available for monobromobimane and ethyl n-alpha-acetyl-tyrosinate
| Article | Year |
|---|---|
The mechanism of cell-mediated cytotoxicity. III. Protease-specific inhibitors preferentially block later events in cytotoxic T lymphocyte-mediated lysis than do inhibitors of methylation or thiol-reactive agents.
Topics: Adenosine; alpha 1-Antichymotrypsin; Animals; Bridged Bicyclo Compounds; Calcium; Chymotrypsin; Coformycin; Cytotoxicity, Immunologic; Deoxyadenosines; Methylation; Mice; Mice, Inbred Strains; Pentostatin; Peptide Hydrolases; Sulfhydryl Compounds; T-Lymphocytes, Cytotoxic; Time Factors; Tyrosine | 1983 |